microdosing glp 1 peptides GLP-1 & Benefits of GLP-1 Microdosing GLP-1

Physiology of the incretin hormones, GIP and GLP-1regulation of release and posttranslational modifications

Pescador, N

In Alzheimers disease (AD), both preclinical and clinical studies have demonstrated consistent benefits

Dual and triple agonists Tirzepatide is the first dual GIP/GLP-1 receptor agonist

I am not sure a once daily injection will become favorable again unless the cost difference is significant (both insurance and out of pocket)

The NO pathway is especially important in endothelial cells, as PKA activates NO synthase (NOS), which can produce more nitric acid and does result in reduced small intestine, large intestine, and colon motility